Your browser doesn't support javascript.
loading
Current status of antimicrobial therapy for tuberculosis / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy ; (12): 1437-1440, 2022.
Article Dans Chinois | WPRIM | ID: wpr-955857
ABSTRACT
Multidrug-resistant tuberculosis has a long treatment course and a low sputum-negative conversion rate, which have always been the treatment challenges. New drugs for multidrug-resistant tuberculosis have been constantly explored by scholars worldwide. Multiple antibacterial drugs have been found to have the therapeutic effects on multidrug-resistant tuberculosis. Treatment options that can shorten the duration of tuberculosis are also being explored. Addition of certain antibacterial drugs has been found to shorten the duration of tuberculosis. This paper reviews the effects of antibacterial drugs against tuberculosis.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Primary Medicine and Pharmacy Année: 2022 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Primary Medicine and Pharmacy Année: 2022 Type: Article